Canada
· Delayed Price · Currency is CAD NetraMark Holdings Company Description
NetraMark Holdings Inc. develops artificial intelligence and machine learning solutions for the pharmaceutical industry in Canada.
The company’s product suite comprises Netra Shatter; Netra Health Atlas; and NetraAi that is designed to help interact and explore with different perspective of the data for clinical trials.
It provides NetraPlacebo module that analyzes past trial data to determine what drives placebo responses to guide inclusion/exclusion criteria; and Netra GPT module that offers insights from past clinical trials about the patient’s population by utilizing established medical literature.
The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023.
The company was founded in 2016 and is headquartered in Toronto, Canada.
| Country | Canada |
| Founded | 2016 |
| Industry | Health Information Services |
| Sector | Healthcare |
| CEO | George Achilleos |
Contact Details
Address: 1655 Dupont Street Toronto, British Columbia M6P 3T1 Canada | |
| Phone | 403 681 2549 |
| Website | netramark.com |
Stock Details
| Ticker Symbol | AIAI |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | October - September |
| Reporting Currency | CAD |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| George Achilleos | Chief Executive Officer and Director |
| Josh Spiegel | President |
| Daniel Gallucci | Founder, Chief Performance Officer and Director |
| Dr. Joseph Geraci Ph.D. | Founder, Chief Scientific and Technical Officer and Director |
| Swapan Kakumanu ACA, ACWA, CGA | Chief Financial Officer |
| Jaime Hackett | Vice President of Marketing |
| Dr. Luca Pani M.D. | Chief Innovation and Regulatory Officer and Chief Medical Advisor |
| Dr. Kaveh Kavoosi | Head of Progressive Medicine |
| Dr. Larry Alphs | Chief Medical Officer and Member of Advisory Board |
| Dr. Angelico Carta M.D. | Chief Strategy Officer |